Evidence map›Paper›PMID 29434320›Full record

ArticleScientific reports2018

Host-guest complexes of imazalil with cucurbit[8]uril and β-cyclodextrin and their effect on plant pathogenic fungi.

Naji Al-Dubaili, Khaled El-Tarabily, Na'il Saleh

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 15 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Naji Al-DubailiChemistry Department, College of Science, United Arab Emirates University, P.O. Box, 15551, Al-Ain, United Arab Emirates.
Khaled El-TarabilyBiology Department, College of Science, United Arab Emirates University, P.O. Box, 15551, Al-Ain, United Arab Emirates.
Na'il SalehChemistry Department, College of Science, United Arab Emirates University, P.O. Box, 15551, Al-Ain, United Arab Emirates. n.saleh@uaeu.ac.ae.ORCID 0000-0003-3282-1156
United Arab Emirates University · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the control of imazalil (IMZ) antifungal activity utilizing its non-covalent assembly with β-cyclodextrins (β-CD) and cucurbit[8]uril (CB8) macrocycles, as well as its stimuli-responsive disassembly with cadaverine. The NMR results are consistent with inclusion of a single IMZ molecule inside the cavities of either CB8 from its aromatic site or β-CD from its aliphatic end. Efficient complex formation with both host molecules and controlled released upon the addition of cadaverine is supported by NMR measurements. The stimuli-responsiveness of the same host-guest assemblies with cadaverine was validated against seven economically important plant pathogenic fungi which cause agriculturally important plant diseases across the globe. While loading the drug into macrocycles cavities suppressed its activity, subsequent adding of cadaverine efficiently restored it up. The results in the present paper enable researchers working in the area of mycology and plant pathology to inhibit or reduce the fungal growth on demand in order to control these economically important plant pathogenic fungi.

Indexed as

beta-CyclodextrinsBridged-Ring CompoundsCadaverineCucurbit(n)urilsFungiImidazolesMacrocyclic CompoundsMacromolecular SubstancesMagnetic Resonance SpectroscopyMolecular StructurePlant Diseasesbeta-CyclodextrinsBridged-Ring CompoundsCadaverinecucurbit(8)urilCucurbit(n)urilsenilconazoleImidazolesMacrocyclic CompoundsMacromolecular Substances

Identifiers

PMID29434320
PMCPMC5809605
OpenAlexW2807528110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.